Cargando…
In-Silico Identification of Natural Compounds from Traditional Medicine as Potential Drug Leads against SARS-CoV-2 Through Virtual Screening
The novel coronavirus strain SARS-CoV-2 is the virus responsible for the recent global health crisis, as it causes the coronavirus disease-19 (COVID-19) in humans. Due to its high rate of spreading and significant fatality rates, the situation has escalated to a pandemic, which is the cause of immen...
Autores principales: | Mithilesh, Sai, Raghunandan, Divya, Suresh, P. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741561/ https://www.ncbi.nlm.nih.gov/pubmed/35035034 http://dx.doi.org/10.1007/s40011-021-01292-5 |
Ejemplares similares
-
In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021) -
In silico prediction of the animal susceptibility and virtual screening of natural compounds against SARS-CoV-2: Molecular dynamics simulation based analysis
por: Garg, Priyanka, et al.
Publicado: (2022) -
Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors
por: Salman, Saad, et al.
Publicado: (2020) -
Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach
por: Ali, Shahid, et al.
Publicado: (2022) -
In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein
por: Mathew, Shilu, et al.
Publicado: (2021)